- Home
- BKYI vs LIPO Comparison
BKYI vs LIPO Comparison
Compare BKYI & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- LIPO
- Stock Information
- Founded
- BKYI 1993
- LIPO 2005
- Country
- BKYI United States
- LIPO United States
- Employees
- BKYI N/A
- LIPO N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- LIPO Health Care
- Exchange
- BKYI Nasdaq
- LIPO Nasdaq
- Market Cap
- BKYI 3.5M
- LIPO 3.5M
- IPO Year
- BKYI 1997
- LIPO 2022
- Fundamental
- Price
- BKYI $0.92
- LIPO $2.66
- Analyst Decision
- BKYI
- LIPO Strong Buy
- Analyst Count
- BKYI 0
- LIPO 1
- Target Price
- BKYI N/A
- LIPO $16.00
- AVG Volume (30 Days)
- BKYI 120.0K
- LIPO 169.2K
- Earning Date
- BKYI 11-14-2024
- LIPO 11-14-2024
- Dividend Yield
- BKYI N/A
- LIPO N/A
- EPS Growth
- BKYI N/A
- LIPO N/A
- EPS
- BKYI N/A
- LIPO N/A
- Revenue
- BKYI $7,292,394.00
- LIPO $483,533.00
- Revenue This Year
- BKYI $1.96
- LIPO N/A
- Revenue Next Year
- BKYI $9.65
- LIPO N/A
- P/E Ratio
- BKYI N/A
- LIPO N/A
- Revenue Growth
- BKYI N/A
- LIPO 0.78
- 52 Week Low
- BKYI $0.52
- LIPO $2.21
- 52 Week High
- BKYI $4.12
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- BKYI 41.70
- LIPO 45.43
- Support Level
- BKYI $0.85
- LIPO $2.53
- Resistance Level
- BKYI $1.00
- LIPO $2.79
- Average True Range (ATR)
- BKYI 0.11
- LIPO 0.29
- MACD
- BKYI -0.02
- LIPO -0.01
- Stochastic Oscillator
- BKYI 20.00
- LIPO 12.62
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.